Wladimir Hogenhuis
Direttore/Membro del Consiglio presso REZOLUTE, INC.
Patrimonio netto: 85 002 $ in data 30/04/2024
Posizioni attive di Wladimir Hogenhuis
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| REZOLUTE, INC. | Direttore/Membro del Consiglio | 02/03/2021 | - |
| Independent Dir/Board Member | 02/03/2021 | - | |
GATT Technologies BV
 GATT Technologies BV Medical SpecialtiesHealth Technology GATT Technologies BV develops a soluble surgical tape. It manufactures a polymer-based general adhesive tissue tape that is used as a surgical sealant for various surgical applications. The company was founded in August 2011 by Johan Bender and André de Lege and is headquartered in Nijmegen, the Netherlands. | Direttore/Membro del Consiglio | 01/05/2020 | - |
| IHP Therapeutics, Inc. | Direttore/Membro del Consiglio | - | - |
Driver Bioengineering, Inc.
 Driver Bioengineering, Inc. Medical SpecialtiesHealth Technology Driver Bioengineering, Inc. develops modular, drug-responsive, titratable, ribozyme based control devices for chimeric antigen receptor. It engages in building control systems for chimeric antigen receptor (CAR) T-cell therapeutics. The company was founded by Gusti Zeiner, Christina Smolke and Benjamin Wang on May 12, 2015 and is headquartered in Menlo Park, CA. | Direttore/Membro del Consiglio | 28/04/2022 | - |
| Amministratore Delegato | 28/04/2022 | - | |
| Presidente | 28/04/2022 | - |
Storia della carriera di Wladimir Hogenhuis
Precedenti posizioni note di Wladimir Hogenhuis
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Direttore operativo | 28/09/2018 | 10/01/2020 |
| GSK PLC | Corporate Officer/Principal | 01/12/2012 | 01/09/2018 |
| Vision 2020 | Direttore/Membro del Consiglio | - | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - | - |
Formazione di Wladimir Hogenhuis
| University of Leiden | Doctorate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
| Paesi Bassi | 3 |
| Regno Unito | 2 |
Posizioni
| Director/Board Member | 5 |
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
Settori
| Health Technology | 7 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| GSK PLC | Health Technology |
| REZOLUTE, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
| Vision 2020 | |
GATT Technologies BV
GATT Technologies BV Medical SpecialtiesHealth Technology GATT Technologies BV develops a soluble surgical tape. It manufactures a polymer-based general adhesive tissue tape that is used as a surgical sealant for various surgical applications. The company was founded in August 2011 by Johan Bender and André de Lege and is headquartered in Nijmegen, the Netherlands. | Health Technology |
Driver Bioengineering, Inc.
Driver Bioengineering, Inc. Medical SpecialtiesHealth Technology Driver Bioengineering, Inc. develops modular, drug-responsive, titratable, ribozyme based control devices for chimeric antigen receptor. It engages in building control systems for chimeric antigen receptor (CAR) T-cell therapeutics. The company was founded by Gusti Zeiner, Christina Smolke and Benjamin Wang on May 12, 2015 and is headquartered in Menlo Park, CA. | Health Technology |
| IHP Therapeutics, Inc. |
- Borsa valori
- Insiders
- Wladimir Hogenhuis
- Esperienza
